Feed 603716.SS
60
Thalys Medical Technology Group Inc.
603716.SS · SHH
¥16.69 -2.28% (-¥0.39)
1M +7.42%
Market Cap ¥3.9B
P/E Ratio -
Div. Yield -
ROE 21.18%
Bulios Fair Price
¥13.5
19.1% downside
Current Price
¥16.69
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 603716.SS is currently overvalued relative to its market price. How does it work?
Piotroski F-Score Weak
3/9Valuation
49 /100
Fair P/S 3.64x
P/B 4.14x
P/E N/A
Growth
0 /100
Declining Rev. growth 22.44%
Book val. growth 12.35%
EPS growth N/A
Profitability
7 /100
Weak Gross margin 22.32%
FCF margin 4.04%
Net margin 19.25%
Quality
8 /100
Poor ROIC 16.76%
Asset turnover 0.60x
ROE 21.18%
Debt
62 /100
Moderate Debt/Equity 0.26x
Int. coverage -3.54x
Current ratio 1.42x
Stability
69 /100
Stable Beta 1.00x
Profitable years 0
Rev. volatility 16.88%
Ask StockBot about 603716.SS
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Zheng Wang
Employees
1,045
Headquarters
Wuhan